baber/WOPTO huggingface dataset:
Patent CA-1338779-C (CA)
Title: Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
Inventor: HIND HARRY
IPC: A61P25/04
Filed: 1989-09-25
Granted: 1996-12-10
Abstract: A method is offered for reducing the pain associated with herpes-zoster and post-herpetic neuralgia.  The method consists of administering a composition incorporating a transdermal delivery system to areas of for the administration of lidocaine to areas of the body afflicted by herpes-zoster and post-herpetic neuralgia enclosed with an occlusive dressing or a plaster dressing.
Patent CA-1316047-C (CA)
Title: Press installation for machining sheet-metal parts
Inventor: BRANDSTETTER RUDI
IPC: B21D43/05
Filed: 1989-09-27
Granted: 1993-04-13
Abstract: ABSTRACT OF THE DISCLOSURE A hybrid press installation employs a plurality of individual presses including a drawing press and transfer presses.  These presses, by means of frames, are set up on common installation surfaces.  A tool is assigned to each press which includes a head piece, a slide and a press bed and a sliding table.  The tools can be exchanged by means of the sliding tables.  A transfer device extends through the hybrid press installation, the components of this transfer device being arranged above the sheet metal conveying plane, and gripping the sheet metal parts from above.          Intermediate depositing devices are positioned between two working stages.  As a result, a reduction of the length of the transfer movement of the sheet metal parts per slide stroke is achieved.          In this manner, large-surface and/or thin-walled and therefore unstable sheet metal parts can be transferred.
Patent CA-1333174-C (CA)
Title: 2-azabicyclo¬2.2.1|hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
Inventor: CORTES DAVID A
IPC: C07F9/38
Filed: 1989-09-28
Granted: 1994-11-22
Abstract: A compound having the structure   V   wherein R3, R4, R5, R6, R7 and R8 are each independently hydrogen, C1-C4 alkyl, C6H5 or NO2; Y is COOR, CON(R1)2, or CN wherein R and R1 are each independently hydrogen or C1-C4 alkyl with the proviso that when R3, R4, R5, R6, R7 and R8 are hydrogen, R is independently hydrogen or C2-C4 alkyl.  These compounds are useful as intermediates in the preparation of N-phosphonomethylglycine, a known herbicide and plant growth regulator.
Patent CA-1326489-C (CA)
Title: Intermediates for preparing benzoxazole derivatives
Inventor: IIJIMA IKUO
IPC: C07D277/34
Filed: 1991-10-24
Granted: 1994-01-25
Abstract: ABSTRACT OF THE DISCLOSURE          Intermediates of general formula:                          for preparing novel benzoxazole derivative of the formula:                           wherein R, Alk and ? are defined in the disclosure.  The derivatives and salts thereof are useful as therapeutic agents for diabetes.
Patent DK-165160-C (DK)
Inventor: BRAEUNING EGON
IPC: A47C7/44
Filed: 1985-10-22
Granted: 1993-03-01
Abstract: The seat furniture is provided with a seat-plate backrest inclination-adjusting mechanism (6), a single-column supporting device (2) and a supporting foot (1). The backrest is composed of a backrest bottom part (16) and a backrest top part (14), and when the backrest inclination is fixed the backrest top part (14) can additionally be moved, counter to the pressure exerted by a restoring-spring arrangement (13), so as to swing freely to the rear between a first and a second stop position of an adjusting-spring device (22).
Patent FI-78899-C (FI)
Inventor: GOTTLIEB KLAUS
IPC: B01J31/10
Filed: 1982-04-27
Granted: 1989-10-10
Abstract: A process for producing isopropyl alcohol and isopropyl tert-butyl ether from a mixture of light hydrocarbons containing propane and butane, comprises: (a) separating from the mixture of light hydrocarbons a propane fraction and a butane fraction containing at least n-butane; (b) isomerizing at least a portion of the n-butane in the butane fraction from step (a) whereby a hydrocarbon mixture containing at least n-butane and isobutane is formed; (c) catalytically dehydrogenating the isobutane in the hydrocarbon mixture from step (b) whereby a hydrocarbon mixture containing at least isobutene is produced; (d) catalytically dehydrogenating the propane in the propane fraction from step (a) whereby a hydrocarbon mixture containing at least propene is produced; (e) reacting the propene in the hydrocarbon mixture from step (d) with water, whereby a mixture containing hydrocarbons and isopropyl alcohol is formed; (f) reacting the isopropyl alcohol from step (e) with at least part of the isobutene in the hydrocarbon mixture from step (c) whereby a mixture containing hydrocarbons and isopropyl tert-butyl ether is formed; (g) recycling the hydrocarbons in the hydrocarbon mixture from step (e) to step (d), respectively; (h) recycling the hydrocarbons in the hydrocarbon mixture from step (f) to step (c); and (i) recovering at least the isopropyl tert-butyl ether.
Patent FI-94207-C (FI)
Inventor: HSU JEMIN CHARLES
IPC: A01N43/713
Filed: 1989-12-21
Granted: 1995-08-10
Abstract: Synergistic biocidal compositions of 2-n-octyl-3-isothiazolone and methylene bisthiocyanate are disclosed.
Patent FI-92604-C (FI)
Inventor: SAGAMI HIROSHI
IPC: C25B13/08
Filed: 1990-07-06
Granted: 1994-12-12
Abstract: A cation exchange membrane having high durability, which is adapted for use in electrolysis of an alkali metal chloride, which comprises a quadrilateral base membrane and, disposed on at least one marginal area of one surface of the base membrane, a diffusion coating having a capability for an alkali metal hydroxide to diffuse therethrough at a diffusion velocity greater than that at which the alkali metal hydroxide diffuses through a fluorocarbon polymer layer constituting the base membrane when the base membrane is composed of one fluorocarbon polymer layer or through one outermost layer of the base membrane which layer has thereon the diffusion coating and has a water sorption smaller than that of the opposite outermost layer of the base membrane, when the base membrane is composed of a plurality of fluorocarbon polymer layers. The cation exchange membrane is free, for a prolonged period of time, from the local lowering of the mechanical strength of the membrane as caused by the precipitation of an alkali metal chloride within and the formation of oxygen in nascent state within the base membrane during the electrolysis of an alkali metal chloride.
Patent NO-146985-C (NO)
Inventor: ONDETTI MIGUEL ANGEL
IPC: C07D207/16
Filed: 1977-02-11
Abstract: The compounds of formula I are prepared by N-acylation of a compound of formula II' by means of an acid of formula III'. In these formulae, R is a hydroxyl, NH2 or alkoxy group, R1 and R4 are each H or an alkyl, phenyl or phenylalkyl group, R2 is H or an organic substituent, R3 is H or a hydroxyl or alkyl group, m is 1, 2 or 3 and n is 0, 1 or 2. The acid of formula III' can be replaced by a functional derivative of the latter or, when n is 1, by an acrylic acid of formula R4CH=C(R1)-COOH. In the latter case, after the acylation, a thiol or thioacid R2SH is added to the double bond of the acryloyl residue. The compounds of formula I are therapeutically active in the treatment of blood hypertension (high blood pressure). <IMAGE>
Patent NO-147357-C (NO)
Inventor: BETZL HERMANN
IPC: H01L27/10
Filed: 1979-07-23
Abstract: A filter circuit utilizing charge transfer delay lines having individual CTD elements utilizing four-terminal resonators each of which is designated as a self-contained closed looped circuit and which determine the frequency dependent transmission characteristics of the filter circuit and wherein successive four-terminal resonators are interconnected by way of a coupling circuit. The invention utilizes the coupling circuit mounted between adjacent four-terminal resonators which are constructed simply as possible and utilizing integrated circuit techniques. Amplifiers are connected in parallel with the input and/or the output of the individual four-terminal resonators and the signal flow direction of the amplifiers corresponds to that of parallel connected CTD lines and the series lines of the coupling circuit and the amplifiers have unidirectional transmission characteristics and an inverting amplifier is contained in at least one of the series lines.
Patent NO-151894-C (NO)
Inventor: GARNETT DONALD IRWIN
IPC: B01J27/08
Filed: 1979-08-20
Abstract: A process for preparing a furan compound by the catalytic oxidation of a diolefin such as butadiene or a halo-substituted alkene is provided. ln this process, the starting material is contacted with an aqueous medium having a pH less than about 2 containing (1) iodide ion, (2) a mixture of cuprous and cupric ions, and (3) a solubilizing agent for cuprous ion such as an alkali metal halide. Optionally, an oxygen-containing gas such as air can also be contacted with the aqueous medium. In one embodiment, the starting material is contacted with an aqueous solution of the aforesaid ingredients in one reaction zone to prepare furan and a portion of the solution is passed to a second reaction zone where cuprous ion is oxidized to cupric ion with air and then the air-treated solution returned to the first reaction zone.
Patent NO-164321-C (NO)
Inventor: WINZER GERHARD
IPC: H04J99/00
Filed: 1981-10-02
Abstract: An optical wavelength division multiplex system having a multiplexer unit, a demultiplexer unit and means for forming a transmission path between the two units characterized by each of the multiplexer and demultiplexer units being composed of at least two reflecting grating modules interconnected by at least one interference module which reflection and interference modules of each unit are matched to one another. The system enables increasing the number of transmission channels with different carrier wavelengths while the insertion losses are maintained in an acceptable range.
Patent NO-155052-C (NO)
Inventor: BERCHER HORST
IPC: C07C213/00
Filed: 1982-10-19
Abstract: 1. 1-(2,4-Dichlorophenoxy)-3- (3,4-dimethoxy-beta-phenethylamino)-2-propanol of formula I  see diagramm : EP0086256,P7,F1  as racemate or in optically active form.
Patent NO-169773-C (NO)
Inventor: SUGIHARA HIROSADA
IPC: C07D411/06
Filed: 1984-12-12
Abstract: Novel 1,5-benzoxathiepin derivatives of the formula: <CHEM> [wherein R1 and R2 are independently hydrogen, halogen, hydroxy, lower alkyl or lower alkoxy; R3 and R4 are independently hydrogen, optionally substituted lower alkyl or optionally substituted cycloalkyl or optionally substituted aralkyl, or both jointly form an optionally substituted ring together with the adjacent nitrogen atom; X is hydrogen, optionally substituted lower alkyl, optionally substituted aryl or a carboxyl group which may be esterified or amidated; Y is  &rdurule& C=O or  &rdurule& CH-OR5 (wherein R5 is hydrogen, acyl or optionally substituted carbamoyl); m is an integer of 0 to 2; n is an integer of 1 to 6] and salts thereof exhibit serotonin S2 receptor blocking activity, calcium antagonism, actions to relieve cerebral vasospasm and to improve renal circulation and diuretic and antithrombotic activities, and are of value as a prophylactic and therapeutic agent for ischemic cardiopathies, thrombosis, hypertension and cerebral circulatory disorders.
Patent NO-167197-C (NO)
Inventor: HUCHETTE MICHEL FRANCAISE
IPC: C04B24/38
Filed: 1985-08-05
Abstract: 1. Process for the manufacture of gypsum boards, characterized by the fact there is used as a bonding agent protective colloid, an amount of amylaceous material representing from 0.2 to 2 % by weight with respect to the weight of plaster employed, said amylaceous material comprising, on the one hand, a proportion of at least 30 %, preferably at least 45 % by weight of particles of native wheat starch of dimension less than 10.7 mu m and, on the other hand, a proportion of at the most 20 % by weight of particles of native wheat starch of dimension greater than 35 mu m, the presence of these two granulometric fractions being determined by a method A of analysis.
Patent NO-179162-C (NO)
Inventor: LONG JR DAVID M
IPC: A61K31/02
Filed: 1988-08-04
Abstract: Fluorocarbon emulsions for use in or with animal bodies and organs thereof, maintains emulsion stability through normal sterilization procedures with selective osmotic and buffering agents, maintains the emulsion at within predetermined osmolarity levels and, when desired, free of excessive calcium precipitation, reduces in vivo and in vitro red blood cell injury, reduces adverse anemia effects, reduces viscosity and reduces the rate of oxidation, and tends to equilibrate its distribution in major body organs thereby reducing toxicity. The osmotic agents may buffer and may provide nutrient in the form of sugars. The osmotic and buffering agents can comprise, selectively, hexahydric alcohols, namely mannitol and sorbitol; certain sugars, namely glucose, mannose and fructose; along with buffering agents that will affect osmolarity including imidazole, tris(hydroxymethyl)aminomethane, sodium chloride, sodium bicarbonate, monobasic potassium phosphate, dibasic potassium phosphate, calcium chloride, magnesium sulfate, monobasic sodium phosphate, dibasic sodium phosphate or combinations of them. The emulsion may include tocopherol. A method of emulsifying the fluorocarbon includes forced flow impingement under pressure after mixing the fluorocarbon into the discontinuous phase. The fluorocarbon emulsion can be used to deliver drugs and medicines soluble in, or transportable by the emulsion.
Patent NO-169093-C (NO)
Inventor: FREY YVONNE
IPC: C06D3/00
Filed: 1988-12-23
Abstract: For producing artificial mist for civil and military applications, briquetted combustible masses are used, which are distributed as small shot by means of thrower charges. The mist sets used are in most cases toxic substances which are a hazard to the environment, at least if they are not or only partially burnt off. 
<??>According to the invention, a device is provided which consists of non-toxic hygroscopic mist sets (1) which are enveloped on all sides by a moisture-insensitive igniting layer (2). An ammunition body (5) contains mist sets (1, 3) in various sizes and geometries and enables a large target area to be misted up over the entire ground. 
<??>In addition, a preferred production process for mist sets and for the igniting layer thereof is described. 
<IMAGE>
Patent NO-170011-C (NO)
Inventor: KIENZLE FRANK
IPC: C07D333/20
Filed: 1989-06-09
Abstract: The propanolamine derivatives of the formula 
<IMAGE>
 in which R<1>, R<2>, R<3> and R<4> have the meanings indicated in the description, and the physiologically tolerated salts thereof have catabolic action and can be used for treating obesity, diabetes and conditions associated with increased protein breakdown, or as feed additive for fattening livestock. 
<??>They can be prepared by reduction of appropriate monoester monoamides of malonic acid or corresponding propanolamides.
Patent NO-178737-C (NO)
Inventor: TARALDSSON LEIF BORJE
IPC: E04G9/05
Filed: 1993-12-22
Abstract: PCT No. PCT/SE92/00473 Sec. 371 Date Dec. 21, 1993 Sec. 102(e) Date Dec. 21, 1993 PCT Filed Jun. 25, 1992 PCT Pub. No. WO93/00494 PCT Pub. Date Jan. 7, 1993.A mould-form shuttering panel against which concrete is intended to be cast. The shuttering panel is wood based, such as plywood, wherein the side of the shuttering panel intended to lie in contact with the concrete includes an elastic layer which will not adhere to the concrete to any significant extent. The elastic layer is 1-5 mm in thickness and is applied to the plywood by a method including spraying the layer onto the plywood and then rolling a roller over the liquid coating.
Patent AU-778172-C (AU)
Title: A stent graft having a pleated graft member
Inventor: BUTARIC FRANK
IPC: A61F2/06
Filed: 2001-11-02
Granted: 2005-06-30
Abstract: In accordance with the present invention there is provided a stent graft for insertion into a body lumen, such as a blood vessel, in order to repair such lumen. The stent graft includes a substantially cylindrical hollow expandable stent comprising a plurality of interconnected struts. The stent has a distal end and a proximal end, and an interior surface and an exterior surface. At least one strut of the stent has first and second apertures extending therethrough from the interior surface to the exterior surface. The stent graft also includes a graft member covering a predetermined portion of least one of the interior surface and the exterior surface of the stent. In addition, the stent graft further includes a staple for attaching the graft member to the stent. The staple has a crown and two legs extending therefrom. At least one of the legs of the staple extends through the graft material and through the first aperture. Both of the legs are bent inwardly towards said crown such that they evert back and extend through the second aperture. <IMAGE>
Patent CA-2001727-C (CA)
Title: Organic compounds
Inventor: RUDOLPH FREDERICK
IPC: A23L33/00
Filed: 1989-10-30
Granted: 1998-02-17
Abstract: The invention provides immunostimulatory compositions comprising an aggregate immunostimulatory amount of a) a compound associated with the synthesis of polyamines, b)   a nucleobase source, c)   omega-3 polyunsaturated fatty acids, and  d)   omega-6 polyunsaturated fatty acids the use of such compositions and their manufacture.
Patent CA-2006929-C (CA)
Title: Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
Inventor: GUY RACHEL
IPC: A61P31/04
Filed: 1989-12-29
Granted: 2005-10-18
Abstract: This invention provides plasmids for bacterial expression of polypeptides which comprise a substantial portion of the amino acid sequence of, and which have the biological activity of, one of the domains of naturally-occurring human fibronectin, such as the cell binding domain or fibrin binding domain, comprising DNA encoding the polypeptide and DNA encoding suitable regulatory elements positioned relative to the DNA encoding the polypeptide so as to effect expression of the polypeptide in a suitable host cell. In the presently preferred embodiments of the invention, the polypeptide is a 75 kD, 40 kD or 33 kD polypeptide of the cell binding domain, or a 31 kD or 20 kD polypeptide of the fibrin binding domain. The invention also provides methods for producing the polypeptides and pharmaceutical compositions comprising the polypeptides and pharmaceutically acceptable carriers. The polypeptides of this invention may be used to inhibit platelet aggregation, to inhibit thromboxane release from platelets, or to treat a subject with a cerebrovascular disorder, a cardiovascular disorder, a wound, a bacterial infection, a cancer, or to detect a fibrin thrombi. The invention further provides the polypeptides conjugated to thrombolytic agents, growth factors, serum albumin, blood factors, or polyethyleneglycol.
Patent CA-2007425-C (CA)
Title: Method and apparatus for gutting fish
Inventor: URUSHIBARA SEIICHI
IPC: A22C25/14
Filed: 1990-01-09
Granted: 1995-03-21
Abstract: An apparatus  for carrying out a method for gutting fish is provided, which comprises in combination a conveyor including a number of  segments  at  given  intervals  in  a  direction  substantially perpendicular with respect to its moving direction and operating at a given speed in a certain direction, a rotary cutter for cutting off a head of a fish placed and carried on the conveyor while the venter located within the segment  leads and the head is projected from one side edge of the conveyor, a retainer for retaining the fish to be beheaded in place,  a  plate  for forcing the dorsal region of  the beheaded fish onto the conveyor by the action of a spring, a guide plate fixed at a position where it comes into engagement with a cut end of the beheaded fish forced onto the conveyor by the plate, and a guts squeezer member formed of an elastomer adpated to be forcedly slid over the venter of the fish from the anus toward the cut end, the fish being now in engagement with the fixed guide plate and forced by the plate.
Patent CA-2008345-C (CA)
Title: Method to prepare pigmented lacquers or varnishes for the coloring of contact lenses, the pigmented or colorless lacquers thus obtained and the contact lenses colored with said lacquers
Inventor: PFORTNER TOMAS
IPC: B29D11/00
Filed: 1990-01-23
Granted: 2001-03-13
Abstract: Pigmented lacquers or varnishes for coloring contact lenses are prepared by prepolymerizing under UV radiation half of a mixture of: 60 to 70 weight % of N-vinyl-2-pyrrolidone, 8 to 12 weight % of hydroxyethyl methacrylate, 0.3 to 1 weight % of reticulant components, up to 13 weight % of cyclohexyl methacrylate or acrylate, 8 to 15 weight % of glycidyl acrylate or methacrylate, as binding agent, up to 1 weight % of acrylic or methacrylic acid, 0.1 to 0.5 weight % of UV pho-to:initiator of polymerization, under stirring and at ambient temperature, during a period of time sufficient to form a mass of oily consistency, which when radiation is turned off and is rapidly cooled in a -30°/-40° C bath, changes into a gel storable at low temperatures: extracting the free monomers from the gel until an easily malleable paste if formed; letting the paste settle at ambient temperature, so that it may lose by exudation the remainder of free monomers it might contain; dissolving this paste with part of the aforesaid mixture of liquid monomers without prepolymerization, in ponderal relation sufficient to form a solution at a temperature not higher than ambient temperature, then filtering and recovering a transparent, colorless and curable lacquer, to be kept between -18°/-25° C; and pigmenting the lacquer and mixing it with the necessary quantity of the chosen micronized pigments. The method of the invention enables to obtain pigmented or colorless lacquers or varnishes which are storable during periods of up to 6 months with no unfavorable changes and, consequently, ready to be used.
Patent CA-2021550-C (CA)
Inventor: SHROOT BRAHAM
IPC: C07C27/02
Filed: 1990-07-19
Granted: 2001-09-04
Abstract: Acide 6-3-(1-adamantyl)-4-méthoxyphényl -2-naphtoïque marqué au tritium; préparation et utilisation de ce composé notamment comme marqueur radioactif dans le dosage des récepteurs nucléaires des rétinoides, en particulier en présence de CRABP contaminante, ou dans la mesure de l'affinité de substances telles que des rétinoïdes pour ces récepteurs nucléaires.
Patent CA-2025940-C (CA)
Title: Closure for a container
Inventor: WITT STEPHEN H
IPC: B65D51/20
Filed: 1990-09-21
Granted: 1998-09-15
Abstract: A closure for a container has two parts, namely an inner sealing member and an outer cap.   The inner sealing member has a tab extending down between a bottle neck and a depending side wall of the cap.   The tab is folded around the cap wall to form an upwardly extending portion.  A patch of adhesive secures this tab portion to the cap.  This prevents unauthorized removal of the cap and  provides  visible  and  external  evidence  of  any tampering.
Patent CA-2035643-C (CA)
Title: Flange type duct connector
Inventor: ARNOLDT PETER J
IPC: F16L23/14
Filed: 1991-02-04
Granted: 2000-04-11
Abstract: A duct connector frame having frame sections with a bottom wall, a front wall, a top wall and a rear wall. The rear wall extends downwardly at an angle to the front wall and forms a generally triangular opening in the frame section. A channel shaped pocket ar support member is formed in the opening to receive and support the lower edge of a corner piece leg portion and the rear wall, adjacent the top wall, has an inturned portion that forms a stop within the opening for the upper rear surface of the corner piece leg portion. The support member and the stop maintain the corner piece leg portion in the opening in fixed abutting relation with the rear surface of the frame front wall.